重新审视未成年女性盆腔CT的妊娠筛查策略:患者特异性胎儿与有效剂量估算
该回顾性研究纳入102例12-18岁女性,行优化剂量盆腔CT用于股骨前倾角评估和手术规划,基于NCICT数据库估算患者特异性胎儿(子宫)吸收剂量和有效剂量。结果显示平均有效剂量0.54±0.20 mSv,平均子宫吸收剂量1.57±0.67 mGy,远低于20 mGy的尿液/血清妊娠试验筛查阈值,提示仅靠口头确认即可安全进行此类检查。
要点
- 优化剂量盆腔CT的胎儿剂量远低于20 mGy阈值,或可仅口头筛查妊娠。
- 有效剂量和子宫剂量与患者年龄、体重相关性弱,与CTDIvol强相关(R=0.79)。
- 建议重新评估未成年女性盆腔CT的常规尿液/血清妊娠筛查流程。
局限性
- 回顾性研究设计。
- 单中心研究。
- 样本量有限(102例)。
- 剂量估算基于体模匹配而非实际测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Only verbal pregnancy screening is recommended for post-menarcheal females undergoing pelvic radiographs. In contrast, usually, a urine/serum pregnancy test for pelvic computed tomographic (CT) exams is required out of concern for higher radiation exposure.
OBJECTIVE: To estimate patient-specific fetus absorbed dose to a potentially pregnant minor from an optimized dose CT of the pelvis for femoral version and surgical planning and provide evidence that such examinations of the pelvis can be performed with only verbal pregnancy screening.
METHODS AND METHODS: A retrospective study was performed on 102 female patients between 12-18 years of age (15.4 ± 2.1 years) who underwent optimized dose CT of the pelvis for orthopedic evaluation of femoral version and surgical planning. Optimized CT exams were performed with weight-adjusted kVp and tube current modulation. Patient-specific dose from the optimized dose CT was calculated using the National Cancer Institute Dosimetry System for CT (NCICT) database by matching each patient to a phantom from the NCI non-reference phantom library based on patient sex, weight, and height. The calculated absorbed uterus dose was used as a surrogate for the fetus dose. Furthermore, patient-specific organ doses were used to estimate the effective dose. The strengths of the linear relationships between the dose metrics and patient characteristics were assessed using Pearson correlation coefficients through linear regression.
RESULTS: The mean patient-specific effective dose for an optimized dose CT of the pelvis was 0.54 ± 0.20 mSv (range: 0.15-1.22 mSv). The mean estimated absorbed uterine dose was 1.57 ± 0.67 mGy (range: 0.42-4.81 mGy). Both effective dose and estimated uterine dose correlated poorly with patient physical characteristics (R = -0.26; 95% CI: [-0.43, -0.007] for age, R = 0.03; 95% CI: [-0.17, 0.22] for weight) but correlated strongly (R = 0.79, 95% CI: [0.7, 0.85]) with CTDIvol.
CONCLUSION: The estimated fetus dose in case of pregnancy was significantly lower than 20 mGy for urine/serum pregnancy screening, suggesting that the pregnancy screening protocols in minors undergoing optimized dose CT require reassessment and may be safely performed by verbal attestation only.
引用
- Nosrati R, Callahan MJ, Tsai A, et al. Reconsidering pregnancy screening policies for minors: patient-specific estimate of fetus and effective dose for potentially pregnant minors undergoing optimized dose CT of the pelvis. Pediatr Radiol. 2023. PMID: 37423916. doi:10.1007/s00247-023-05715-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。